Home Cart Sign in  
Chemical Structure| 20315-25-7 Chemical Structure| 20315-25-7

Structure of Procyanidin B1
CAS No.: 20315-25-7

Chemical Structure| 20315-25-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Procyanidin B1, a natrual product isolated and prufied from the fruits of Vitis vinifera L., inhibits infection by vesicular stomatitis virus and HCV pseudotype virus in Huh-7 cells, with IC50 of 29μM and 15μM, respectively.

Synonyms: Procyanidol B1; Epicatechin-(4beta->8)-ent-epicatechin; Proanthocyanidin B1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Procyanidin B1

CAS No. :20315-25-7
Formula : C30H26O12
M.W : 578.52
SMILES Code : O[C@H]1[C@@H](C2=CC=C(O)C(O)=C2)OC3=C(C(O)=CC(O)=C3)[C@@H]1C4=C(O)C=C(O)C5=C4O[C@H](C6=CC=C(O)C(O)=C6)[C@@H](O)C5
Synonyms :
Procyanidol B1; Epicatechin-(4beta->8)-ent-epicatechin; Proanthocyanidin B1
MDL No. :MFCD01861512
InChI Key :XFZJEEAOWLFHDH-UKWJTHFESA-N
Pubchem ID :11250133

Safety of Procyanidin B1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BEnd.3 cells 394 µM 48 hours No significant toxicity Phytother Res. 2024 Dec;38(12):5583-5597
GL261 cells 394 µM 48 hours Inhibited GL261 cell proliferation Phytother Res. 2024 Dec;38(12):5583-5597
PC12 cells 2.5 µM and 5 µM 24 hours To evaluate the protective effect of Procyanidin B1 on MPP+-induced PC12 cell damage. Results showed that 5 µM Procyanidin B1 significantly improved cell viability, reduced LDH leakage, decreased ROS and MDA content, increased antioxidant enzyme activity, and upregulated the expression of Nrf2/ARE pathway-related proteins. Molecules. 2022 Aug 6;27(15):5007
U251 cells 394 µM 48 hours Inhibited U251 cell proliferation and downregulated NRF2 expression Phytother Res. 2024 Dec;38(12):5583-5597

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6N mice Intracranial glioblastoma orthotopic model Oral administration 15 mg/kg Once daily for 44 days Inhibited tumor growth and prolonged survival Phytother Res. 2024 Dec;38(12):5583-5597
C57BL/6J mice High-fat-diet-induced diabetic model Oral 150 mg/kg, 250 mg/kg Once daily for 8 weeks Procyanidin B1 and coumaric acid alleviated high-fat-diet-induced hyperlipidemia by activating PPARα expression, regulating hepatic lipid metabolism and gut microbiota. Results showed that supplementation with PB and CA significantly decreased serum total cholesterol (TC), triglyceride (TG), and low-density lipoprotein (LDL-C) levels, and increased high-density lipoprotein (HDL-C) levels. Additionally, PB and CA improved gut microbiota dysbiosis, reducing the relative abundance of Ruminococcaceae and increasing the relative abundance of Lactobacillus, Desulfovibrio, and Akkermansia. Foods. 2024 Jun 12;13(12):1843
Zebrafish Parkinson's disease model Water immersion 25 µM 4 days To evaluate the protective effect of Procyanidin B1 on the zebrafish Parkinson's disease model. Results showed that 25 μM Procyanidin B1 significantly improved motor ability, reduced dopaminergic neuron damage, decreased MDA content, increased antioxidant enzyme activity, and upregulated the expression of Nrf2/ARE pathway-related genes. Molecules. 2022 Aug 6;27(15):5007

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.73mL

0.35mL

0.17mL

8.64mL

1.73mL

0.86mL

17.29mL

3.46mL

1.73mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories